Picture

Mary L. (Nora) Disis @DrNDisis

Director, UW Medicine Cancer Vaccine Institute. Editor in Chief, JAMA Oncology. Research: vaccines for the prevention of cancer and cancer relapse. uwcvi.org University of Washington Joined February 2015
  • Tweets
    1K
  • Followers
    2K
  • Following
    172
  • Likes
    49
DrNDisis Profile Picture

Mary L. (Nora) Disis @DrNDisis

a year ago

x.com/uwcancervaccin…

UWCancerVaccine Profile Picture

UW Cancer Vaccine Institute @UWCancerVaccine

a year ago

x.com/uwcancervaccin…

Mary L. (Nora) Disis retweeted
UWCancerVaccine Profile Picture

UW Cancer Vaccine Institute @UWCancerVaccine

3 years ago

We’re excited to share a new paper by CVI’s Dr. John Liao on a clinical trial for combination Pembrolizumab and low dose carboplatin in women with recurrent, platinum resistant ovarian cancer. Read more uwcvi.org/post/new-cvi-p… #ovariancancerawarenessmonth #gyncsm #immunotherapy

Mary L. (Nora) Disis retweeted
science_seattle Profile Picture

Science in Seattle @science_seattle

3 years ago

👨‍⚕️👩‍⚕️ Drs. Sasha Stanton (@sestant29), Nora Disis (@DrNDisis), and fellow @UWCancerVaccine researchers found that candidate targets recovered from mouse #mammary tumor models are also immunogenic in human #BreastCancer. 📚 Abstact: go.nature.com/3y780Vb

Mary L. (Nora) Disis retweeted
uwmnewsroom Profile Picture

UW Medicine Newsroom @uwmnewsroom

4 years ago

5 immune response markers might predict #COVID19 patient outcomes & possibly become useful in candidate vaccine assessment, according to @ImmunityCP @CellCellPress study @ragoninstitute & @UWMedicine headed by Galit Alter & Helen Chu bit.ly/2DrtULn

Mary L. (Nora) Disis retweeted
JackWestMD Profile Picture

H. Jack West, MD @JackWestMD

4 years ago

In the wake of #ADAURA trial, what will your practice be for molecular testing in patients with resected stage IB-IIIA NSCLC? Please amplify as needed in the comments. #LCSM

Mary L. (Nora) Disis retweeted
0131Liu Profile Picture

Ying.Liu.0131 @0131Liu

4 years ago

Thanks for my nicest colleagues! I am the best, because all of you! @UWCancerVaccine

UWCancerVaccine Profile Picture

UW Cancer Vaccine Institute @UWCancerVaccine

4 years ago

Thanks for my nicest colleagues! I am the best, because all of you! @UWCancerVaccine

DrNDisis Profile Picture

Mary L. (Nora) Disis @DrNDisis

4 years ago

Laura is an amazing scientist!

UWCancerVaccine Profile Picture

UW Cancer Vaccine Institute @UWCancerVaccine

4 years ago

Laura is an amazing scientist!

DrNDisis Profile Picture

Mary L. (Nora) Disis @DrNDisis

5 years ago

Pembrolizumab After Locally Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer ja.ma/2O5xGif New at @jama Onc-ablation of oligometastatic NSCLC followed by immune checkpoint: OS at 12 mo-90%. Novel and promising application of immune checkpoint inhibition.

DrNDisis Profile Picture

Mary L. (Nora) Disis @DrNDisis

5 years ago

Regulatory roles of IL-10–producing human follicular T cells jem.rupress.org/content/early/…

DrNDisis Profile Picture

Mary L. (Nora) Disis @DrNDisis

5 years ago

I'm a fan of testing early. Immune therapy more be more effective with less bulky disease.

TomJayram Profile Picture

Tom Jayram @TomJayram

5 years ago

I'm a fan of testing early. Immune therapy more be more effective with less bulky disease.

Mary L. (Nora) Disis retweeted
guptaarjun90 Profile Picture

Arjun Gupta @guptaarjun90

5 years ago

Patient page on #CIPN (Chemo Induced Peripheral Neuropathy), in @JAMAOnc w/ @TimothyJBrownMD @ramsedhom #QOL matters. Can be photocopied non-commercially to share with patients. jamanetwork.com/journals/jamao…

DrNDisis Profile Picture

Mary L. (Nora) Disis @DrNDisis

5 years ago

Thank you UW CVI #ImmunoOnc19 @UWCancerVaccine

Dr_RaviMadan Profile Picture

Ravi A Madan M.D. @Dr_RaviMadan

5 years ago

Thank you UW CVI #ImmunoOnc19 @UWCancerVaccine

DrNDisis Profile Picture

Mary L. (Nora) Disis @DrNDisis

5 years ago

VERY IMPORTANT COMMENT!!! #ImmunoOnc19 @UWCancerVaccine

fireflyann Profile Picture

A.n.n. @fireflyann

5 years ago

VERY IMPORTANT COMMENT!!! #ImmunoOnc19 @UWCancerVaccine

DrNDisis Profile Picture

Mary L. (Nora) Disis @DrNDisis

5 years ago

Dr. Kandalaft points out that there are many types of antigens that can be used for vaccination, neo antigens of all types- not just point mutations. Target epigenetic changes, phospho Ag...etc. #ImmunoOnc19 @UWCancerVaccine

DrNDisis Profile Picture

Mary L. (Nora) Disis @DrNDisis

5 years ago

Dr. Palucka highlights the importance of DC in mediating response to ICI. Recent Immunity paper implicated IFN-g and IL-12 in T cell DC cross-talk. bit.ly/2tHGyxp #ImmunoOnc19 @UWCancerVaccine

DrNDisis Profile Picture

Mary L. (Nora) Disis @DrNDisis

5 years ago

Dendritic cells are the most important antigen presenting cells for stimulating T-cell responses to cancer. Nobel Prize winning tumor immunologist Dr. Ralph Steinman was honored for his work in this area. #ImmunoOnc19

DrNDisis Profile Picture

Mary L. (Nora) Disis @DrNDisis

5 years ago

Dr. Palucka highlights the issues associated with mutated antigen vaccines; the mutations have to be presented enodogenously in the patients MHC. Most are not. #Immunotherapy #immunoonc19 @UWCancerVaccine

DrNDisis Profile Picture

Mary L. (Nora) Disis @DrNDisis

5 years ago

Sounds exciting for endometrial cancer! #ImmunoOnc19

DrNDisis Profile Picture

Mary L. (Nora) Disis @DrNDisis

5 years ago

Surely there must be more data supporting a Phase III than just these 20 patients....!!!!#ImmunoOnc19

DrBetofMDPhD Profile Picture

Allison Betof Warner, MD, PhD @DrBetofMDPhD

5 years ago

Surely there must be more data supporting a Phase III than just these 20 patients....!!!!#ImmunoOnc19

DrNDisis Profile Picture

Mary L. (Nora) Disis @DrNDisis

5 years ago

Many talks are associating PD-L1 tumor expression with clinical outcome- yet don't tell us definition of PD-L1 positivity. Is it 50%, 5%, 1%? On tumor? On immune "hot-spots"? on APC? Hard to figure out the utility of association. #ImmunoOnc19 @UWCancerVaccine

Trends for United States

FaZe
11,5 B posts
Tory Taylor
5.023 posts
Shipley
5.083 posts
#KristiNoemIsAMonster
12,6 B posts
TJ Tampa
7.372 posts
Braelon Allen
3.873 posts
Ray Davis
2.885 posts
#StumpTheTruck
Feds
18,1 B posts
Cade Stover
3.595 posts
Jaylen Wright
6.511 posts
#Caturday
14,5 B posts
Achane
1.136 posts
Mostert
Niang
2.460 posts
$GPU
6.962 posts
Jaden Hicks
3.377 posts
Antony
51,2 B posts
#UWCL
13,8 B posts
Javon Baker
10,6 B posts

You might like

Medical Oncologist, Clinical Trialist. @JITCancer Interim EiC. #Immunotherapy & #ProstateCancer. All tweets / comments are my own. 🇺🇸🇬🇧🇹🇻🇵🇭🇯🇵🇲🇽
@gulleyj1
@gulleyj1
8K Followers
Chief Medical Officer, American Society of Clinical Oncology (ASCO). Tweets are my own.
Julie Gralow
@jrgralow
10K Followers
Roy Herbst
@DrRoyHerbstYale
6K Followers
@ASCO President. Representing nearly 50K oncology professionals making a difference in cancer care. Opinions my own. Interviews: mediateam@asco.org
Lynn M. Schuchter, MD..
@ASCOPres
9K Followers
CEO of the American Society of Clinical Oncology. Opinions are his and not necessarily @ASCO's.
Clifford Hudis
@CliffordHudis
9K Followers
Immunotherapy of Cancer • Melanoma • Phase I Clinical Trials • Lab: @ImmunoTiil • Disclosures: https://t.co/p3vwd3bi9o
Jason Luke, MD, FACP
@jasonlukemd
6K Followers
I am a medical oncologist and the Principal Investigator of the American Society of Clinical Oncology TAPUR study. Tweets are my own.
Richard Schilsky
@rschilsky
9K Followers
Harder Chair #FoxLab @ChilesResearch /CEO @UbiVac #immunotherapy/@OHSUSOM /exPres&Ambassador @SITCancer /ex @theNCI /exDetroiter/M GO BLUE/❤️Pinot/Tweets my own
Bernard A Fox
@BernardAFox
6K Followers
Chief of Research and Immunotherapy • ImmunoOncology • Phase I Clinical Trials • Melanoma • Cutaneous Oncology
Omid Hamid MD
@OmidHamidMD
5K Followers
Sarah Cannon physician executive and clinical researcher. All opinions are my own.
Skip Burris
@BurrisSkip
3K Followers
VP of Clin Development, @summitplc; Founder,@CancerGRACE; fmr author/ed @UptoDate, fmr Web Ed @JAMAOnc & @MedscapeOnc columnist; Likes/RTs ≠ endorsement
H. Jack West, MD
@JackWestMD
22K Followers
https://t.co/fhghWCmS2m • Cancer Immunology • Developmental Therapeutics • Phase I trials • Genitourinary Oncology • Tweets are my own & not medical advice
Randy Sweis
@RandySweisMD
2K Followers
Medical oncologist with focus on kidney cancer, immunotherapies and the tumor microenvironment. Views expressed are my own. #kidneycancer #immunotherapy
Hans Hammers
@HHammersMD
4K Followers
Chief Scientific Officer, Sarah Cannon Research Institute; Thoracic Medical Oncology, SCRI Oncology Partners
David R. Spigel, MD
@DavidRSpigel
3K Followers
Co-author of the cancer-immunity cycle and the immune set point with Ira Mellman; Opinions are my own.
Dan Chen
@DanChenMDPhD
3K Followers